Veracyte Inc (NASDAQ: VCYT) has reported E.P.S. of $0.07 for its second fiscal quarter (ending June 30) versus $-0.12 for the same period a year ago. Relative to the consensus estimate of $-0.01, this was a premium of $0.08. For the latest four quarters through June 30, E.P.S. were $-0.75 compared to $-0.40 a year ago.
Recent Price Action
Veracyte Inc (NASDAQ: VCYT) stock closed at $21.82 on 8/6/24 after a large increase of 3.9%. Moreover, above average trading volume at 138% of normal accompanied the advance. The stock has declined -5.3% during the last week and has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be below the cost of capital, VCYT is expected to continue to be a modest Value Eraser.
Veracyte has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing highly consistent signals. Veracyte has a poor Appreciation Score of 30 and a poor Power Rating of 26, triggering the Lowest Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment